Breast cancer is the most common malignancy in women worldwide. Metastasis is the
leading cause of high mortality in most cancers. Although predicting the early stage of breast …

Triple-negative breast cancer (TNBC) is associated with high recurrence rates, high
incidence of distant metastases, and poor overall survival (OS). Taxane and anthracycline …

Metaplastic breast carcinoma (MpBC) is a rare special histologic subtype of breast
carcinoma characterized by the presence of squamous and/or mesenchymal differentiation …

Metaplastic breast cancer (MpBC) is a rare, aggressive breast cancer (BC) histotype. Scarce
information is available about MpBC genetic predisposition. Previous studies, mainly …

Abstract Purpose: Metaplastic breast cancer (MpBC) is a rare subtype of breast cancer that
is commonly triple-negative and poorly responsive to neoadjuvant therapy in retrospective …

Purpose The prognostic and therapeutic power of special histological subtypes in breast
cancer in pure form or in combination with other histological subtypes is still not established …

The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German
Gynecological Oncology Group, AGO) presents the 2021 update of the evidence-based …

Introduction Neoadjuvant chemotherapy (NAC) for breast cance has not been well studied
for metaplastic breast cancer (MBC), a rare but aggressive type of breast cancer. Materials …

Metaplastic breast cancer (MpBC) is a rare and aggressive histologic subtype of breast
cancer (BC) characterized by the presence of at least two cellular types, commonly epithelial …

Abstract Objective Metaplastic breast cancer (MpBC) is an aggressive subtype of all breast
cancer. We aimed to investigate the clinicopathological features, treatments and prognoses …